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Background: In Pakistan Fagonia olivieri (Zygophyllaceae) is commonly used in the indigenous system of medicine
for treatment of conditions like diabetes, cancer, fever, asthma, toothache, stomach troubles and kidney disorders.
This study evaluated the crude methanol extract of F. olivieri (FOM) and its derived fractions for their antimicrobial
and cytotoxic activities as well as the classes of phytochemical.
Methods: Dried powder of whole plant of F. olivieri was extracted with methanol (FOM) and the resultant was
fractionated to give n-hexane fraction (FOH), chloroform fraction (FOC), ethyl acetate fraction (FOE), n-butanol
fraction (FOB) and residual aqueous fraction (FOA). Methanol extract and its derived fractions were subjected to
phytochemical screening using standard procedures. Also the extract and fractions were assayed for antibacterial,
antifungal and cytotoxic activities using agar well diffusion technique, agar tube dilution method and brine shrimps
lethality test, respectively.
Results: The results obtained for phytochemical analysis indicate the presence of saponins and alkaloids in all the
tested extract and fractions while anthraquinones were not detected. The results showed that all the bacterial
strains tested in this study were susceptible to at least one of the fractions tested. However, FOE and FOB were the
best antibacterial fractions and showed antibacterial activity against maximum number of bacterial strains. The
results showed that Escherichia coli was the most sensitive bacterium while Bordetella bronchiseptica and
Enterobacter aerogenes were less susceptible against various fractions. Maximum percent inhibition for growth was
recorded for the fungus Aspergillus flavus with FOE whereas growth of Aspergillus fumigatus and Fusarium solani was
inhibited by FOM and its all derived fractions. Minimum LC50 (24.07 mg/L) for brine shrimp assay was recorded for
FOE followed by LC50 of FOC (26.1 mg/L) and FOB (30.05 mg/L) whereas maximum LC50 was exhibited by FOH
(1533 mg/L).
Conclusion: These results indicated the use of F. olivieri to treat infections with emphasis to isolate and characterize
the active principle responsible for antibacterial, antifungal and cytotoxic activities and its exploitation as
therapeutic agent.
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In many countries plants are used as a source of medi-
cines to treat infections and other disorders and some of
the most powerful and potent drugs used nowadays were
derived from plants [1]. Various parts of plant (root, fruit,
stem, flower, modified plant organs and twigs exudates)
having different therapeutic properties are used as herbal
medicines. They are collected on a minute scale to utilize
by folk healers and local communities, while several others
are collected as raw material in larger amounts to trade
them in the market for numerous herbal industries [2].
In recent years a large number of plants have been in-
vestigated for their antimicrobial properties as an integra-
tive system of medicine for protection and management
against pathogens. Use of plant extracts having antimicro-
bial potential can be of great significance to treat human
pathogenic diseases. Natural bioactive compounds in
plants play a key role in plants defense system and are also
well known for their unambiguous physiological action on
human body. Amino acids, proteins common sugars and
chlorophyll are plants primary metabolites whereas sec-
ondary metabolites comprise of flavonoids, alkaloids,
tannins, saponins, and terpenoids. In view of the tremen-
dous importance of secondary metabolites as therapeutic
agents; they are becoming parts of the integrative health
care system as alternative or supportive medicines [3].
The indiscriminate use of commercial antimicrobial
drugs for curing infectious diseases has lead to the devel-
opment of multiple drug resistance in human pathogenic
microorganisms. In addition, a variety of side effects like
allergic reactions, hypersensitivity and immune suppres-
sion are occasionally associated with antibiotics. Further,
food preservation requires evaluation of natural resources
such as herbal fractions and isolates with antimicrobial
properties as the long historic use of herbs has proved
their safety and efficacy in various traditional medicine
systems. Recent trends for the use of natural remedies as
antimicrobial have increased their use in food, cosmetic
and pharmaceutical products which have been screened
in vitro and indicated antimicrobial and other diverse
properties.
Therefore there is a great interest for making new
drugs and to avoid food spoilage by the development of
novel effective compounds [4]. They would have vast
therapeutic potential as they will mitigate many of the
adverse effects that are often coupled with synthetic an-
timicrobials. One of the valuable means used to screen
bioactive compounds from plant extracts is brine shrimp
lethality assay [5]. It is considered as a convenient probe
for primary evaluation of toxicity [6].
Fagonia olivieri belongs to the Zygophyllaceae family,
which has about 25 genera and 240 species [7]. In Pakistan
Zygophyllaceae family is represented by 8 genera and 22
species, whereby it is commonly found in dry hills areas ofKhyber Pakhtoon Khawa and Baluchistan province. The
chief genera of the family are Fagonia, Zygophyllum,
Gauiacum and Tribulus [8]. Various members of this fam-
ily are known for their medicinal uses. In our search for
ethnomedicine, we found that extract of F. olivieri have
been widely used for the management of diabetes and
cough [9]. In addition it is described as a cooling agent
and blood purifier [9]. In the indigenous system of medi-
cine, aqueous decoction of aerial parts of F. olivieri is a
popular remedy for the cancer in its early stages and for
the treatment of various blood vascular and digestive
system disorders [10]. The proposed pharmacological ac-
tivities have not been reported for the whole plant extract
of F. olivieri. The main objectives of the present study
were to screen and evaluate antibacterial, antifungal, cyto-
toxic activities by using brine shrimps lethality assay and
phytochemical analysis of crude methanol extract and its
derived fractions.
Methods
Whole plant of F. olivieri was collected from Rawalpindi
Pakistan. Methanol, n-hexane, ethyl acetate, chloroform,
n-butanol, sulphuric acid, hydrochloric acid, glacial acetic
acid, ferric chloride, sodium hydroxide, benzene, ammo-
nium hydroxide were purchased from Wako Co. (Osaka,
Japan). Dimethyl sulphoxide (DMSO), roxythromycin,
cefixime and terbinafine were procured from Sigma Co.
(St. Louis, MO, USA). Nutrient agar and sabouraud dex-
trose agar was procured from Merck (Germany). Standard
mild resistant isolates of bacteria; Escherichia coli ATCC
15224, Pseudomonas aeruginosa ATCC 27853, Staphylo-
coccus aureus ATCC 6538, Klebsiella pneumonia MTCC
618, Bordetella bronchiseptica ATCC 4617, Micrococcus
luteus ATCC 10240, Enterobactor aerogenes ATCC 13048
and fungi; Aspergillus niger, Aspergillus flavus, Aspergil-
lus fumigatus, Fusarium solani, and Mucor piriformis
were obtained from Laboratory of Molecular Biology
Department of Biochemistry Quaid-i-Azam University
Islamabad, Pakistan.
Collection, extraction and fractionation of plant materials
Whole plant samples of F. olivieri were collected from
Dhamyal Rawalpindi, Pakistan in May, 2010 and identi-
fied by Dr. Saleem Ahmad, Principal Scientific Officer,
Pakistan Museum of Natural History, Islamabad. Vou-
cher specimen was deposited at Pakistan Museum of
Natural History (Voucher No. 058608).
Plant samples were collected in cotton bags and dried
under shade for one month. The material was ground
using a grinder into a fine powder. Two kilogram of
ground material was soaked in 4 L of methanol for one
week and filtered. The material was again extracted with
4 L of methanol and filtered after one week. Two perco-
lates were mixed and dried under vacuum in a rotary
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(FOM). Four gram of the crude extract was suspended
in 200 ml of distilled water and partitioned with n-
hexane (FOH), chloroform (FOC), ethyl acetate (FOE),
n-butanol (FOB) and residual aqueous fraction (FOA).
Determination of the phytochemical constituents
The FOM and its derived fractions were evaluated for the
occurrence of flavonoids, tannins, saponins, phlobatannins,
cardiac glycosides, alkaloids, terpenoids and anthraquinone
using simple qualitative methods.
Salkowski test for terpenoids
To a 5 ml of extract and each fraction 2 ml of chloroform
was added and followed by addition of 3 ml of concen-
trated H2SO4. At interface a reddish brown coloration is
formed if terpenoid constituent is present [11].
Test for alkaloids
Exactly 0.5 g of extract and each fraction was warmed
with 8 ml of 1% HCl and filtered. Two milliliters of each
filtrate was titrated separately with (a) Mayer’s reagent
and (b) Dragendroff ’s reagent. The presence of alkaloids
was indicated by the formation of cream or yellow pre-
cipitate [11].
Test for saponins
About 0.2 g of the crude extract and each fraction was
added to 20 ml of distilled water and boiled in a water
bath and filtered. An aliquot of 5 ml of distilled water
was mixed with 10 ml of the filtrate and shake it vigor-
ously. Formation of emulsion was observed after mixing
the frothing with 3 drops of olive oil and shaken vigor-
ously [11].
Test for phlobatannins
In a small tube 80 mg of crude extract and each frac-
tion was boiled in 1% aqueous hydrochloric acid; for-
mation of red precipitate indicated the presence of
phlobatannins [12].
Keller- Kiliani test (for de-oxy sugars in cardiac glycosides)
From the crude extract and each fraction, 5 ml of
aqueous extract (10 mg/ml) was mixed with 2 ml of gla-
cial acetic acid having a drop of ferric chloride solution
followed by 1 ml of concentrated H2SO4. The character-
istic feature of deoxysugars in cardenolides is the forma-
tion of brown ring at interphase [12].
Test for coumarins
About 0.3 g of extract and each fraction was taken in a
test tube. Filter paper moistened with 1 N NaOH solu-
tion was used to cover the mouth of the tube. Test tube
was placed in boiling water for few minutes. Filter paperwas removed to examine under UV light. The presence
of coumarins is indicated by yellow fluorescence [12].Test for anthraquinones
Briefly, 1.0 g of extract and each fraction was boiled in 1%
HCl and filtered. To the filtrate 5 ml of benzene was
added and in the benzene layer after shaking 10% NH4OH
was added and color in the alkaline phase was observed.
Formation of pink/violet or red color indicated the pres-
ence of anthraquinones [12].Test for tannins
About 0.5 g of the extract and each fraction was mixed
with 20 ml of water in a test tube and filtered. Formation
of blue black or brownish green color after treating fil-
trate with a few drops of 0.1% ferric chloride indicated
the presence of tannins [13].Test for flavonoids
A portion of the aqueous filtrate of extract and each
fraction was mixed with 5 ml of dilute ammonia solution
and concentrated H2SO4 was added. A yellow coloration
is observed if flavonoid compounds are present [13].Antimicrobial assays
Preparation of bacterial/fungal inoculums
Four isolated colonies were inoculated in the 30 ml nutri-
ent broth and incubated for 24 h at 37°C so that the
growth in the broth was equivalent with McFarland stand-
ard (0.5%).Antibacterial activity
Antibacterial activity of plant extract and its derived
fractions was investigated by agar well diffusion method
[14] using nutrient agar medium. Exactly 2 g of nutrient
agar was dissolved in 100 ml of distilled water (pH 7.0)
and was autoclaved. It was cooled down to 45°C. Then
100 ml of this media was seeded with 1 ml of inoculum
having size of 106 CFU/ml as per McFarland standard
and after proper homogenization 75 ml was poured into
the petri plate of 14 cm diameter. For agar well diffusion
method, eleven wells per plate were made with the help
of a sterile cup-borer (8 mm). Extract and fractions at
concentration of 25, 15, 12.5, 10, 7.5, 5, 3, 2 and 1 mg/
ml were prepared in DMSO. The test samples (100 μl)
were poured into the wells and petri plates were then in-
cubated at 37°C for 24 h. Simultaneously, roxythromycin
and cefixime were used as positive controls whereas
DMSO was used as a negative control. The lowest con-
centration inhibiting growth was taken as the minimum
inhibitory concentration (MIC).
Table 1 Phytochemical constituents of F. olivieri
methanol extract and its fractions
Phytochemical
constituents
Extract and fractions
FOM FOH FOC FOE FOB FOA
Tannins + - - - - +
Saponins + + + + + +
Flavonoids + - - - + +
Alkaloids + + + + + +
Cardiac glycosides + + - + - +
Terpenoids + + - + + +
Phlobatannins - - - + - -
Coumarins + - - + + -
Anthraquinones - - - - - -
+, present; -, absent.
FOM; F. olivieri methanol extract, FOH; F. olivieri n-hexane fraction, FOC;
F. olivieri chloroform fraction, FOE; F. olivieri ethyl acetate fraction, FOB;
F. olivieri n-butanol fraction, FOA; F. olivieri residual aqueous fraction.
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Agar tube dilution method was used to evaluate the an-
tifungal activity [15]. The stock solution of extract, frac-
tions and positive control; terbinafine were prepared by
dissolving the extract and fractions in DMSO at a con-
centration of 12 mg/ml. The negative control was
DMSO. Media for fungus was made by dissolving 6.5 g
of sabouraud dextrose agar in 100 ml of distilled water
(pH 5.6). Then 4 ml of it was added into screw cap
tubes. These tubes were autoclaved for 15 min at 120°C
and then cooled down to 45°C. The stock solution
(66.6 μl) was mixed with media to give the final concen-
tration of 200 μg/ml of sabouraud dextrose agar. Tubes
were then solidified in the slanted position at 25°C. An
agar surface streak was employed by inoculating each
tube with a piece (4 mm diameter) of inoculum taken
from a seven days old culture of fungi. Fungal growth
inhibition was observed visually after 7 days of incuba-
tion at 28 ± 1°C. The percent inhibition of growth was
calculated with reference to the negative control.Table 2 The MIC values of F. olivieri crude extract and fractio
Bacteria Minimu
FOM FOH FOC F
Staphylococcus aureus 10 5 -
Micrococcus luteus 7.5 7.5 7.5
Escherichia coli 3 3 3
Klebsiella pneumoniae 12.5 15 7.5
Bordetella bronchiseptica - - -
Enterobactor aerogenes - - -
Pseudomonas aeruginosa 3 15 15 1
- = not active against tested microorganism.
FOM; F. olivieri methanol extract, FOH; F. olivieri n-hexane fraction, FOC; F. olivieri chl
fraction, FOA; F. olivieri residual aqueous fraction.Brine shrimp lethality assay
Hatching of brine shrimps
Brine-shrimp eggs (Artemia salina) were used to find out
the cytotoxicity of the extract and various fractions.
Hatching tray was half filled with saline solution (28 g sea
commercial salt, Sigma USA, was dissolved in one litre of
distilled H2O) and shrimp eggs were sprinkled into it. The
tray was placed at room temperature (25 – 29°C) in the
presence of florescent lamp for 24 h. Eggs were hatched
after incubation and the test samples were used for cyto-
toxicity potential of the extract and fractions.
Assay procedure
This assay was performed by using the method of Meyer
et al. [16]. Different concentrations of the extract and
fractions; 1000 mg/L, 100 mg/L and 10 mg/L were pre-
pared in DMSO and used against brine shrimp larvae.
The survival rate of these larvae was observed against all
concentrations of the extract and different fractions. For
this purpose, 0.5 ml sample of each fraction was trans-
ferred in 20 ml vial, followed by the addition of 2 ml of
sea commercial salt water. Ten shrimps transferred into
each vial, final volume was adjusted to 5 ml by artificial
seawater. All the vials were incubated for 24 h under
florescence light at room temperature (25–29°C) and the
survivors were counted with the help of magnifying glass.
Percentage mortality was determined for three replica-
tions. LC50 values were calculated by using probit analysis
of Biostat software (version 2009).
Results and discussion
Ethnopharmacology is the most common approach used
for selecting the plants for pharmacological studies [17].
Since different plant parts can be used to cure diarrhoea,
cough, cold, fever bronchitis, cholera etc.; therefore they
are proved to be a significant source of potentially helpful
structures for the development of novel chemotherapeutic
drugs [18,19]. In the present era, due to the onward march
of civilization the plentiful resources of medicinal plantsns
m inhibitory concentration (mg/ml)
OE FOB FOA Roxithromycin Cefixime
3 - - 0.2 0.02
3 15 15 0.06 0.05
3 5 2 0.14 0.03
5 10 25 0.17 0.13
- 3 - 0.14 0.16
- 5 - 0.16 0.15
2.5 10 12.5 0.14 0.12
oroform fraction, FOE; F. olivieri ethyl acetate fraction, FOB; F. olivieri n-butanol
Table 3 Antifungal activity of the crude extract and various fractions of F. olivieri
Fungi Percent inhibition (%) (200 μg/ml) Positive control
FOM FOH FOC FOE FOB FOA Terbinafine (200 μg/ml)
Aspergillus niger 15 42.1 25 36.8 0 0 100
Aspergillus fumigatus 30.8 16.6 33.3 25 41.7 35 100
Aspergillus flavus 50 31.6 0 78.9 40 0 100
Fusarium solani 22.2 35 30 5.2 15 55.5 100
Mucor piriformis 0 11.8 11.8 0 0 0 100
FOM; F. olivieri methanol extract, FOH; F. olivieri n-hexane fraction, FOC; F. olivieri chloroform fraction, FOE; F. olivieri ethyl acetate fraction, FOB; F. olivieri n-butanol
fraction, FOA; F. olivieri residual aqueous fraction.
Table 4 Illustration of % age mortality of brine shrimps
at different concentrations of extract and fractions and
respective LC50 values
Extracts % Mortality at various concentrations
1000 mg/L 100 mg/L 10 mg/L LC50 (mg/L)
FOM 56.66 41.66 27.66 356.4
FOH 47.66 31.33 17.66 1533
FOC 78.66 67.66 38.66 26.10
FOE 98.66 74.33 47.66 24.07
FOB 85.33 64.33 37.66 30.05
FOA 72.33 48.66 28.66 101.2
FOM; F. olivieri methanol extract, FOH; F. olivieri n-hexane fraction, FOC;
F. olivieri chloroform fraction, FOE; F. olivieri ethyl acetate fraction, FOB;
F. olivieri n-butanol fraction, FOA; F. olivieri residual aqueous fraction.
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rural population of Pakistan still mainly depends on the
indigenous system of medicine [21]. Keeping in view the
traditional uses of the plant, we carried out in vitro bio-
logical screening of methanol extract and its derived frac-
tions of herbal medicine F. olivieri. It is well known that
the bioactive phytocomponents are responsible for the
medicinal value of the plants [22]. Hence the study of
plant constituents can help explain scientifically the trad-
itional use of these plants.
The results of the phytochemical analysis indicated the
existence of saponins, alkaloids, cardiac glycosides, flavo-
noids and tannins in FOM and all other fractions. How-
ever cardiac glycosides were not determined in FOC and
FOB. The plant constituents of FOM herein presented
was instigated by other reports where saponins, alka-
loids, cardiac glycosides, flavonoids and tannins have
been detected in methanol extract of Fagonia cretica
[23]. Presence of anthraquinones was not established in
FOM and in all other fractions. Results obtained in this
study are in line to other reports where anthraquinones
were not detected in F. cretica [23]. Phlobatannins were
only present in FOM and FOE fraction. However, terpe-
noids were detected in FOM and in all fractions except
in FOC fraction (Table 1). Similar plant constituents
have been detected in Fagonia indica [24,25].
The systemic screening of plant extracts for antibacter-
ial activity is a continuous effort to find new antibacter-
ial compounds. The test organisms used in this study
are related with diverse forms of human infections.
From a medical viewpoint, E. coli results into septicemia
and infection of lungs, gall bladder, skin lesions and
meninges, and also a number of food related diseases
that manifest themselves in the form of diarrhea [26,27].
S. aureus causes boil, ulcers, food poisoning, toxic shock
and pneumonia etc.
Methanol extract and its all derived fractions of F. olivieri
were tested at various concentrations (1.0 ~ 25.00 mg/ml),
against E. coli ATCC 15224, P. aeruginosa ATCC 27853, S.
aureus ATCC 6538, K. pneumonia MTCC 618, B.
bronchiseptica ATCC 4617, M. luteus ATCC 10240, E.
aerogenes ATCC 13048 and the evaluated MIC values arereported in Table 2. Methanol extract of F. olivieri and
FOH exhibited low level of minimum inhibitory concentra-
tion (MIC) against E. coli (MIC = 3 mg/ml) while moderate
level of MIC was manifested against M. luteus (MIC =
7.5 mg/ml). However, MIC values for FOM and FOH were
12.5 mg/ml and 15.0 mg/ml for K. pneumonia, respect-
ively. Similarly S. aureus and P. aeruginosa were reported
the most susceptible bacteria against the methanol extract
of F. cretica [23].
Similarly FOE showed low level of MIC against S. aureus,
E. coli, M. luteus (MIC = 3 mg/ml) and K. pneumoniae
(MIC = 5 mg/ml); whereas MIC value recorded against P.
aeruginosa was 12.5 mg/ml and no activity was detected
against rest of the strains. Likewise FOC, FOB and FOA
had low level of MIC values against E. coli, while higher
MIC values were recorded for K. pneumoniae.
Antibacterial activities of plant extracts can be
explained on the basis of their chemical constituents.
From the results it is depicted that E. coli is the most
susceptible while the K. pneumoniae and P. aeruginosa
were less susceptible. Similar results have been deter-
mined for various extracts of F. indica [25]. Presence of
different bioactive constituents; saponins, flavonoids and
alkaloids in the extract and various fractions might con-
tribute towards diversified antibacterial activities.
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an important factor for morbidity and mortality in im-
mune compromised patients [28]. The majority of the
fungal infections are mainly caused by the Aspergillus
species [29]. Therefore the plant extract and all fractions
have been screened for antifungal activity against A.
niger, A. flavus, A. fumigatus, F. solani, and M. piriformis
using agar tube dilution method. The drug used as a
standard was terbinafine.
The growth inhibition for the extract and fractions
was measured and represented in Table 3. FOB and FOA
did not show any inhibition in growth of A. niger while
maximum inhibition was exhibited by FOH followed by
FOE, FOC and FOM. Aspergillus flavus was the most
sensitive fungus in this study with highest growth inhib-
ition (78.9%) was recorded for FOE fraction. However, M.
piriformis was less susceptible fungus and its growth was
inhibited (11.8%) by FOH and FOC fraction.
Brine shrimps cytotoxicity assay has been considered
as pre-screening assay for antimicrobial, antitumor, anti-
malarial and insecticidal activities. Therefore it is sug-
gested to be a convenient probe for the pharmacological
activities of plant extracts [30]. The brine shrimps lethal-
ity assay was used to assess the toxicity of F. olivieri.
The test samples (crude and fractions) were used in con-
centrations of 10, 100 and 1000 mg/L.
Results for the lethality were noted in terms of deaths
of larvae (% age mortality) of brine shrimp. The FOM
showed cytotoxic activity (LC50 = 356.4 mg/L) for the
experimental shrimps. Different fractions exhibited var-
ied cytotoxic activities. The LC50 value calculated was
1533 mg/L for FOH whereas LC50 for FOE was 24.07 mg/L.
The FOC showed LC50 = 26.1 mg/L for brine shrimp le-
thality assay. Similarly, the FOB exhibited LC50 value of
30.05 mg/L whereas 101.2 mg/L was determined for FOA.
The cytotoxic results of the samples are presented in
Table 4.
The spectra of antimicrobial activities displayed by the
extract and fractions could perhaps be explained by the
presence of different plant constituents. The mode of
action of antibacterial effects of saponins may involve
damage to the membrane causing leakage of cellular
materials, finally leading to cell death [31]. This anti-
microbial activity of F. olivieri may be correlated well
with the presence of saponins. Similar findings have
been reported for antimicrobial and cytotoxicity studies
in other reports [23,25].
Flavonoids and tannins are effective antimicrobial sub-
stances possibly due to their capability to interact with
soluble and extracellular proteins and to intricate with
bacterial cell walls leading to the death of the bacteria
[32]. The results presented in this study were concurrent
with the above findings. Similar antimicrobial results
have been reported in earlier studies [23,25].Conclusion
The result of this study signifies the potential of F.
olivieri as a source of therapeutic agent. Further studies
on the purification of bioactive components can depict
the exact potential(s) of the plant to restrain a number
of pathogenic microbes as the purified components may
have even more effectiveness with respect to inhibition
of microbes. Furthermore, the activity exhibited by the
extracts for brine shrimps and microbes that are associ-
ated with various infectious diseases, may offer scientific
justification for the ethnomedicinal use of the plant.
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